“Integrated Efficacy of FMX101 4% Topical Minocycline Foam for the Treatment of Moderate-to-Severe Acne Vulgaris: Analyses of Efficacy in Clinically Relevant Subgroups of Patients”. 2020. SKIN The Journal of Cutaneous Medicine 4 (6): s89. https://doi.org/10.25251/skin.4.supp.89.